Atlas Trials

Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer

Clinical trial NCT07066969 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07066969
Sponsor
European Institute of Oncology
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2026-01-22
Primary completion
2027-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.